(Q36872739)

16 August 2017

1 reference

title

Pharmacogenomics and adverse drug reactions in diagnostic and clinical practice (English)

1 reference

16 August 2017

1 reference

Vangelis G Manolopoulos

series ordinal

1

1 reference

16 August 2017

1 January 2007

1 reference

Clinical Chemistry and Laboratory Medicine

16 August 2017

1 reference

16 August 2017

45

1 reference

16 August 2017

801-814

1 reference

16 August 2017

7

1 reference

Pharmacogenomic-guided rational therapeutic drug monitoring: conceptual framework and application platforms for atypical antipsychotics

16 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.184

Therapeutic monitoring of antidepressants in the era of pharmacogenetics studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.184

Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.184

The pharmacogenetics research network: from SNP discovery to clinical drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.184

Appropriateness of therapeutic drug monitoring for antidepressants in routine psychiatric inpatient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.184

Pharmacogenetic methods as a complement to therapeutic monitoring of antidepressants and neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2007.184

21 January 2018

Identifiers

DOI

10.1515/CCLM.2007.184

1 reference

16 August 2017

1 reference

PubMed ID

17617019